TY  - RPRT
TI  - First-in-patient dose prediction for adeno-associated virus-mediated hemophilia gene therapy using allometric scaling
AU  - Zou, P.
PY  - 2022
DO  - 10.1101/2022.07.05.498837
UR  - https://www.biorxiv.org/content/10.1101/2022.07.05.498837v1
ID  - 10.1101/2022.07.05.498837
ER  -